Short- and long-term surgical outcomes in patients undergoing proctocolectomy with ileal pouch-anal anastomosis in the setting of primary sclerosing cholangitis

Kellie L. Mathis, Luis A. Benavente-Chenhalls, Eric Dozois, Bruce G. Wolff, David Larson

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

BACKGROUND: Primary sclerosing cholangitis occurs in approximately 10% of patients with ulcerative colitis, but studies involving IPAA in patients with cholangitis have been reported in limited numbers. OBJECTIVE: This study aimed to examine surgical outcomes in patients with ulcerative colitis and sclerosing cholangitis undergoing total proctocolectomy with IPAA and to identify variables associated with surgical complications. DESIGN: This is a retrospective cohort study. SETTINGS: This study was conducted at a single tertiary referral institution. PATIENTS: Included were all patients with cholangitis and ulcerative colitis who underwent proctocolectomy with IPAA from 1994 to 2005. MAIN OUTCOME MEASURES: Perioperative morbidity, long-term pouch function, and pouch survival were the main outcome measures. RESULTS: One hundred patients (62 male) were studied. Forty-three percent were on steroids. There was no perioperative mortality, and 51 30-day complications occurred in 39 patients (39%). Median follow-up time was 5.9 years (range, 0.14 -16.2 y). Pouch failure occurred in 3 patients (3%). The single variable that predicted 30-day morbidity was previous abdominal surgery (P= .03). Prednisone use, body mass index, age, ASA score, preoperative Model for End Stage Liver Disease score, and year of surgery were not significantly associated with short-term complications. CONCLUSIONS: IPAA can be performed safely in the setting of sclerosing cholangitis. The preoperative Model for End-stage Liver Disease Score and the use of preoperative immunosuppressive agents are not associated with an increased risk of complications. The likelihood of long-term pouch survival is excellent.

Original languageEnglish (US)
Pages (from-to)787-792
Number of pages6
JournalDiseases of the Colon and Rectum
Volume54
Issue number7
DOIs
StatePublished - Jul 2011

Fingerprint

Colonic Pouches
Sclerosing Cholangitis
Ulcerative Colitis
End Stage Liver Disease
Cholangitis
Morbidity
Survival
Immunosuppressive Agents
Prednisone
Body Mass Index
Cohort Studies
Referral and Consultation
Retrospective Studies
Steroids
Outcome Assessment (Health Care)
Mortality

Keywords

  • Ileal pouch-anal anastomosis
  • Sclerosing cholangitis
  • Surgical outcomes
  • Ulcerative colitis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Short- and long-term surgical outcomes in patients undergoing proctocolectomy with ileal pouch-anal anastomosis in the setting of primary sclerosing cholangitis. / Mathis, Kellie L.; Benavente-Chenhalls, Luis A.; Dozois, Eric; Wolff, Bruce G.; Larson, David.

In: Diseases of the Colon and Rectum, Vol. 54, No. 7, 07.2011, p. 787-792.

Research output: Contribution to journalArticle

@article{bf94c88486894c0eb8532e15ffbe15f2,
title = "Short- and long-term surgical outcomes in patients undergoing proctocolectomy with ileal pouch-anal anastomosis in the setting of primary sclerosing cholangitis",
abstract = "BACKGROUND: Primary sclerosing cholangitis occurs in approximately 10{\%} of patients with ulcerative colitis, but studies involving IPAA in patients with cholangitis have been reported in limited numbers. OBJECTIVE: This study aimed to examine surgical outcomes in patients with ulcerative colitis and sclerosing cholangitis undergoing total proctocolectomy with IPAA and to identify variables associated with surgical complications. DESIGN: This is a retrospective cohort study. SETTINGS: This study was conducted at a single tertiary referral institution. PATIENTS: Included were all patients with cholangitis and ulcerative colitis who underwent proctocolectomy with IPAA from 1994 to 2005. MAIN OUTCOME MEASURES: Perioperative morbidity, long-term pouch function, and pouch survival were the main outcome measures. RESULTS: One hundred patients (62 male) were studied. Forty-three percent were on steroids. There was no perioperative mortality, and 51 30-day complications occurred in 39 patients (39{\%}). Median follow-up time was 5.9 years (range, 0.14 -16.2 y). Pouch failure occurred in 3 patients (3{\%}). The single variable that predicted 30-day morbidity was previous abdominal surgery (P= .03). Prednisone use, body mass index, age, ASA score, preoperative Model for End Stage Liver Disease score, and year of surgery were not significantly associated with short-term complications. CONCLUSIONS: IPAA can be performed safely in the setting of sclerosing cholangitis. The preoperative Model for End-stage Liver Disease Score and the use of preoperative immunosuppressive agents are not associated with an increased risk of complications. The likelihood of long-term pouch survival is excellent.",
keywords = "Ileal pouch-anal anastomosis, Sclerosing cholangitis, Surgical outcomes, Ulcerative colitis",
author = "Mathis, {Kellie L.} and Benavente-Chenhalls, {Luis A.} and Eric Dozois and Wolff, {Bruce G.} and David Larson",
year = "2011",
month = "7",
doi = "10.1007/DCR.0b013e318217eea7",
language = "English (US)",
volume = "54",
pages = "787--792",
journal = "Diseases of the Colon and Rectum",
issn = "0012-3706",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Short- and long-term surgical outcomes in patients undergoing proctocolectomy with ileal pouch-anal anastomosis in the setting of primary sclerosing cholangitis

AU - Mathis, Kellie L.

AU - Benavente-Chenhalls, Luis A.

AU - Dozois, Eric

AU - Wolff, Bruce G.

AU - Larson, David

PY - 2011/7

Y1 - 2011/7

N2 - BACKGROUND: Primary sclerosing cholangitis occurs in approximately 10% of patients with ulcerative colitis, but studies involving IPAA in patients with cholangitis have been reported in limited numbers. OBJECTIVE: This study aimed to examine surgical outcomes in patients with ulcerative colitis and sclerosing cholangitis undergoing total proctocolectomy with IPAA and to identify variables associated with surgical complications. DESIGN: This is a retrospective cohort study. SETTINGS: This study was conducted at a single tertiary referral institution. PATIENTS: Included were all patients with cholangitis and ulcerative colitis who underwent proctocolectomy with IPAA from 1994 to 2005. MAIN OUTCOME MEASURES: Perioperative morbidity, long-term pouch function, and pouch survival were the main outcome measures. RESULTS: One hundred patients (62 male) were studied. Forty-three percent were on steroids. There was no perioperative mortality, and 51 30-day complications occurred in 39 patients (39%). Median follow-up time was 5.9 years (range, 0.14 -16.2 y). Pouch failure occurred in 3 patients (3%). The single variable that predicted 30-day morbidity was previous abdominal surgery (P= .03). Prednisone use, body mass index, age, ASA score, preoperative Model for End Stage Liver Disease score, and year of surgery were not significantly associated with short-term complications. CONCLUSIONS: IPAA can be performed safely in the setting of sclerosing cholangitis. The preoperative Model for End-stage Liver Disease Score and the use of preoperative immunosuppressive agents are not associated with an increased risk of complications. The likelihood of long-term pouch survival is excellent.

AB - BACKGROUND: Primary sclerosing cholangitis occurs in approximately 10% of patients with ulcerative colitis, but studies involving IPAA in patients with cholangitis have been reported in limited numbers. OBJECTIVE: This study aimed to examine surgical outcomes in patients with ulcerative colitis and sclerosing cholangitis undergoing total proctocolectomy with IPAA and to identify variables associated with surgical complications. DESIGN: This is a retrospective cohort study. SETTINGS: This study was conducted at a single tertiary referral institution. PATIENTS: Included were all patients with cholangitis and ulcerative colitis who underwent proctocolectomy with IPAA from 1994 to 2005. MAIN OUTCOME MEASURES: Perioperative morbidity, long-term pouch function, and pouch survival were the main outcome measures. RESULTS: One hundred patients (62 male) were studied. Forty-three percent were on steroids. There was no perioperative mortality, and 51 30-day complications occurred in 39 patients (39%). Median follow-up time was 5.9 years (range, 0.14 -16.2 y). Pouch failure occurred in 3 patients (3%). The single variable that predicted 30-day morbidity was previous abdominal surgery (P= .03). Prednisone use, body mass index, age, ASA score, preoperative Model for End Stage Liver Disease score, and year of surgery were not significantly associated with short-term complications. CONCLUSIONS: IPAA can be performed safely in the setting of sclerosing cholangitis. The preoperative Model for End-stage Liver Disease Score and the use of preoperative immunosuppressive agents are not associated with an increased risk of complications. The likelihood of long-term pouch survival is excellent.

KW - Ileal pouch-anal anastomosis

KW - Sclerosing cholangitis

KW - Surgical outcomes

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=80051561938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051561938&partnerID=8YFLogxK

U2 - 10.1007/DCR.0b013e318217eea7

DO - 10.1007/DCR.0b013e318217eea7

M3 - Article

C2 - 21654244

AN - SCOPUS:80051561938

VL - 54

SP - 787

EP - 792

JO - Diseases of the Colon and Rectum

JF - Diseases of the Colon and Rectum

SN - 0012-3706

IS - 7

ER -